Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Braxia Scientific Corp C.BRAX

Alternate Symbol(s):  BRAXF

Braxia Scientific Corp. is a Canada-based medical research and telemedicine company with a clinic that provide ketamine treatments for persons with depression and related disorders. Through its medical solutions, it intends to reduce the illness burden of brain-based disorders, such as major depressive disorder, among others. The Company is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. It seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. The Company has clinic operations in the Canadian cities of Mississauga, Kitchener-Waterloo, Ottawa and Montreal. Its subsidiary, Braxia Health, is engaged in offering rapid onset treatments to aid those suffering from several treatment-resistant conditions, such as depression and bipolar disorder.


CSE:BRAX - Post by User

Comment by Bofovom1on Feb 17, 2021 9:03pm
541 Views
Post# 32592279

RE:They have withdrawn the drafts...Perhaps you might read RM

RE:They have withdrawn the drafts...Perhaps you might read RM

I had to reread the press release a couple times to clarify whether they have a draft submitted for review or not. At first I thought they just withdrawn, it then I noticed they have updated their FAQ section with answers to several questions. Most of them don't reveal anything we didn't already know but they do confirm that they have submitted a new listing statement draft for review. This can be found here. https://champignonbrands.com/faq/
 

I can't say I feel great about the press release but finally a sign of life and some acknowledgement that they f@cked it up and have failed at trying to fix it. Let's hope they've figured it out and that the new CFO was brought on board because he had the qualifications to get this done right 

 

<< Previous
Bullboard Posts
Next >>